2019
DOI: 10.1182/blood.2018893404
|View full text |Cite
|
Sign up to set email alerts
|

EFL1 mutations impair eIF6 release to cause Shwachman-Diamond syndrome

Abstract: Shwachman-Diamond syndrome (SDS) is a recessive disorder typified by bone marrow failure and predisposition to hematological malignancies. SDS is predominantly caused by deficiency of the allosteric regulator Shwachman-Bodian-Diamond syndrome that cooperates with elongation factor-like GTPase 1 (EFL1) to catalyze release of the ribosome antiassociation factor eIF6 and activate translation. Here, we report biallelic mutations in EFL1 in 3 unrelated individuals with clinical features of SDS. Cellular defects in … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
78
0

Year Published

2020
2020
2021
2021

Publication Types

Select...
5
2
1

Relationship

1
7

Authors

Journals

citations
Cited by 55 publications
(79 citation statements)
references
References 52 publications
1
78
0
Order By: Relevance
“…EFL1 encodes a cytoplasmic GTPase that acts in concert with Sdo1, the yeast homolog of the Shwachman–Diamond syndrome protein, to promote release of Tif6 from 60S ribosomal subunits during their final maturation (Menne et al , ). Loss of one copy of the human EIF6 gene is a recurrent finding in bone marrow cells of Shwachman–Diamond syndrome patients and is associated with a relatively benign clinical course (Pressato et al , ; Valli et al , ), suggesting that this bypass suppressor mechanism is conserved from yeast to humans (Weis et al , ; Tan et al , ), and supporting a rationale for the development of small‐molecule eIF6 suppressor mimics for the treatment of Shwachman–Diamond syndrome.…”
Section: Discussionmentioning
confidence: 99%
“…EFL1 encodes a cytoplasmic GTPase that acts in concert with Sdo1, the yeast homolog of the Shwachman–Diamond syndrome protein, to promote release of Tif6 from 60S ribosomal subunits during their final maturation (Menne et al , ). Loss of one copy of the human EIF6 gene is a recurrent finding in bone marrow cells of Shwachman–Diamond syndrome patients and is associated with a relatively benign clinical course (Pressato et al , ; Valli et al , ), suggesting that this bypass suppressor mechanism is conserved from yeast to humans (Weis et al , ; Tan et al , ), and supporting a rationale for the development of small‐molecule eIF6 suppressor mimics for the treatment of Shwachman–Diamond syndrome.…”
Section: Discussionmentioning
confidence: 99%
“…This would suggest that, if the HR defect associated with SBDS mutation contributes to malignant progression, then those with SDS due to EFL1 mutations would not have an increased risk of MDS/AML. None of the 10 patients with biallelic EFL1 variants and SDS have been reported to have MDS or AML (7)(8)(9). Nevertheless, the numbers of patients are too small to draw conclusions at this time.…”
Section: Discussionmentioning
confidence: 89%
“…SBDS activates EFL1 to mediate the eviction of eIF6 from the 60S subunit. Therefore, as an alternative approach to address the importance of ribosome joining, we examined the impact of EFL1 depletion on HR (8). Similar to eIF6 depletion and in contrast to SBDS depletion, EFL1 depletion did not reduce HR efficiency ( Figure, 3C and D).…”
Section: Burwick Et Al Demonstrated That Knockdown Of Eif6 Improved mentioning
confidence: 99%
See 1 more Smart Citation
“…The majority of SDS patients have loss of function mutations in SBDS (SDS1, OMIM #260400) [16]. The best characterized function of SBDS is its role in the release and recycling of eIF6 from pre-60S ribosomes, a process that also involves the GTPase activity of Elongation Factor-Like 1 (EFL1) (SDS2, OMIM # 617941) [17][18][19][20]. The release of eIF6 is a required step in the maturation of the 60S ribosomal subunit [1,3,21,22].…”
Section: Introductionmentioning
confidence: 99%